These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5322748)

  • 21. [The intravenous tolbutamide test in normal subjects].
    Czyzyk A; Kasperska T
    Diabete; 1965; 13(5):183-95. PubMed ID: 5841233
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of sulfonylureas on the permeability to water and electrical properties of the urinary bladder of the toad.
    Urakabe S; Shirai D; Ando A; Takamitsu Y; Orita Y
    Jpn Circ J; 1970 Jul; 34(7):595-601. PubMed ID: 4325174
    [No Abstract]   [Full Text] [Related]  

  • 23. Observations of the mechanism of action of the sulfonylureas under clinical conditions.
    Jackson WP; Van Mieghem W; Keller P
    Metabolism; 1973 Sep; 22(9):1155-62. PubMed ID: 4199277
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of acetohexamide with other sulfonylurea compounds in the treatment of diabetes mellitus.
    Berglund B; Jakobson T
    Acta Med Scand; 1965 Dec; 178(6):735-44. PubMed ID: 5855411
    [No Abstract]   [Full Text] [Related]  

  • 26. [CLINICAL EXPERIENCES WITH A NEW ORAL HYPOGLYCEMIC DRUG, ACETOHEXAMIDE].
    CHANIS RA
    Arch Med Panamenos; 1963 Dec; 12():193-206. PubMed ID: 14161953
    [No Abstract]   [Full Text] [Related]  

  • 27. SERUM CONCENTRATION AND URINARY EXCRETION OF ORAL SULFONYLUREA COMPOUNDS: RELATION TO DIABETIC CONTROL.
    SHELDON J; ANDERSON J; STONER L
    Diabetes; 1965 Jun; 14():362-7. PubMed ID: 14298920
    [No Abstract]   [Full Text] [Related]  

  • 28. ORAL HYPOGLYCEMIC AGENTS.
    THOSTESON GC
    Harper Hosp Bull; 1964; 22():107-10. PubMed ID: 14159416
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute hypoglycemizing activity of intravenous tolazamide and tolbutamide: comparative study in normal, diabetic and hepatopathic man. Preliminary note].
    Milani R
    Minerva Med; 1965 Sep; 56(74):3163-5. PubMed ID: 5833700
    [No Abstract]   [Full Text] [Related]  

  • 30. Status of problem of usage of tolbutamide. Preliminary statements.
    Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
    [No Abstract]   [Full Text] [Related]  

  • 31. Single and combined drug therapy of sulfonylurea failure.
    Abelove WA; Echenique R
    J Fla Med Assoc; 1969 Apr; 56(4):262-3. PubMed ID: 5776594
    [No Abstract]   [Full Text] [Related]  

  • 32. THE ORAL HYPOGLYCEMIC COMPOUNDS.
    FERGUSON BD
    Med Clin North Am; 1965 Jul; 49():929-38. PubMed ID: 14300336
    [No Abstract]   [Full Text] [Related]  

  • 33. SEVERE AND PROLONGED HYPOGLYCEMIC SHOCK DURING SULFONYLUREA TREATMENT.
    BAUER HG
    Metabolism; 1965 Mar; 14():220-8. PubMed ID: 14261406
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acetohexamide (Ordimel) in the treatment of diabetes mellitus].
    Tjorstad KO
    Tidsskr Nor Laegeforen; 1967 Jul; 87(14):1277-9. PubMed ID: 6046773
    [No Abstract]   [Full Text] [Related]  

  • 35. Seminars on diabetes. II. Principles of management.
    Can Med Assoc J; 1971 Nov; 105(9):972-3 passim. PubMed ID: 5150198
    [No Abstract]   [Full Text] [Related]  

  • 36. Long term use of acetohexamide in maturity-onset diabetes mellitus.
    Justiniani FR; Lopez-Gomez AA; Alterman SL
    J Fla Med Assoc; 1969 Mar; 56(3):175-7. PubMed ID: 4890458
    [No Abstract]   [Full Text] [Related]  

  • 37. The comparative clinical effectiveness of tolbutamide and acetohexamide.
    Duncan TG; Smith JB; Duncan GG
    Metabolism; 1968 Mar; 17(3):218-25. PubMed ID: 4867884
    [No Abstract]   [Full Text] [Related]  

  • 38. COMBINED TRIAL OF ACETOHEXAMIDE AND TWO DIGUANIDE PREPARATIONS.
    SZANTO S
    Ir J Med Sci; 1964 Jan; 457():3-11. PubMed ID: 14113902
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chlorpropamide and other oral hypoglycemic agents in the treatment of diabetes mellitus resistant to tolbutamide. Clinico-statistical study].
    Danelon-Martina L
    Clin Ter; 1969 Apr; 49(2):135-46. PubMed ID: 5407314
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of tolbutamide on serum glucose level, specific activity of glucose and glucose oxidation in severe diabetes.
    Adlung J; Koch CD
    Int J Clin Pharmacol; 1974 Sep; 10(2):128-35. PubMed ID: 4448554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.